Cargando…
Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
Background Kaposiform hemangioendothelioma (KHE) is a vascular tumor frequently associated with Kasabach–Merritt phenomenon (KMP), characterized by severe thrombocytopenia and consumptive coagulopathy. Visceral involvement in KHE is rare. In our recent experience, sirolimus has shown to be an effec...
Autores principales: | Triana, Paloma Junco, Dore, Mariela, Nuñez, Vanesa Cerezo, Jimenez, Javier Gomez, Miguel, Miriam Ferrero, Díaz, Mercedes González, Ricardo, Joan Novo, Andres, Ane, Lopez Santamaria, Manuel, Lopez-Gutierrez, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533608/ https://www.ncbi.nlm.nih.gov/pubmed/28761800 http://dx.doi.org/10.1055/s-0037-1604358 |
Ejemplares similares
-
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon
por: Alaqeel, Alaa M., et al.
Publicado: (2016) -
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
por: Cabrera, Trevor B., et al.
Publicado: (2020) -
Penile Reconstruction with Skin Grafts and Dermal Matrices: Indications and Management
por: Triana Junco, Paloma, et al.
Publicado: (2017) -
Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study
por: Wang, Dongdong, et al.
Publicado: (2019) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019)